Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...

WATKINSVILLE, GA / ACCESS Newswire / January 29, 2026 / In an era where staffing shortages, cost containment, and regulatory complexity challenge healthcare operations, pharmacy support offers ...

Healthcare leaders and state lawmakers gathered in Albany on Tuesday to warn that Upstate and rural hospitals are facing mounting financial pressure from potential federal funding cuts and state ...

Faculty from Washington State University’s College of Pharmacy and Pharmaceutical Sciences in Spokane are now providing ...

Pharmacy school applications rise 6% from fall 2024 to 2025, signaling renewed interest and potential workforce growth in ...

Healthcare providers are currently facing yet another termination of Medicare telehealth flexibilities at the end of the day on January 30, 2026, unless Congress acts on proposals to further extend ...

The Trump administration proposed a rule Thursday requiring transparency in pharmacy benefit managers’ compensation and ...

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose and ...

On January 22, the U.S. House of Representatives passed on a bipartisan basis HR 7148, the Consolidated Appropriations Act, 2026 (HR 7148). If it ...

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...

The complaint filed by the AIDS Healthcare Foundation claims that the state illegally changed rules regarding income eligibility thresholds for the AIDS Drug Assistance Program.

The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.